Winslow Evans & Crocker’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$12K Hold
190
﹤0.01% 913
2020
Q3
$9K Hold
190
﹤0.01% 776
2020
Q2
$9K Hold
190
﹤0.01% 759
2020
Q1
$10K Hold
190
﹤0.01% 698
2019
Q4
$12K Hold
190
﹤0.01% 767
2019
Q3
$12K Hold
190
﹤0.01% 753
2019
Q2
$12K Sell
190
-10
-5% -$515 ﹤0.01% 771
2019
Q1
$12K Buy
200
+10
+5% +$509 ﹤0.01% 771
2018
Q4
$10K Hold
190
﹤0.01% 770
2018
Q3
$14K Hold
190
﹤0.01% 736
2018
Q2
$14K Hold
190
﹤0.01% 736
2018
Q1
$10.5K Hold
190
﹤0.01% 772
2017
Q4
$9.09K Hold
190
﹤0.01% 827
2017
Q3
$9.59K Hold
190
﹤0.01% 828
2017
Q2
$10.4K Hold
190
﹤0.01% 908
2017
Q1
$8.01K Sell
190
-2
-1% -$85 ﹤0.01% 936
2016
Q4
$8.15K Hold
192
﹤0.01% 929
2016
Q3
$7.84K Hold
192
﹤0.01% 963
2016
Q2
$7.58K Buy
192
+2
+1% +$72 ﹤0.01% 949
2016
Q1
$6.4K Sell
190
-2
-1% -$62 ﹤0.01% 970
2015
Q4
$6.44K Hold
192
﹤0.01% 1004
2015
Q3
$5.66K Sell
192
-43
-18% -$1.34K ﹤0.01% 1006
2015
Q2
$6.4K Hold
235
﹤0.01% 1031
2015
Q1
$5.86K Hold
235
﹤0.01% 996
2014
Q4
$5.15K Hold
235
﹤0.01% 1037
2014
Q3
$4.72K Buy
235
+3
+1% +$60 ﹤0.01% 1113
2014
Q2
$4.47K Hold
232
﹤0.01% 1056
2014
Q1
$4.37K Hold
232
﹤0.01% 1053
2013
Q4
$5K Buy
+232
New +$4.26K ﹤0.01% 1132

Other funds holding IART

Winslow Evans & Crocker's IART Position: Q4 2020 in Review

Winslow Evans & Crocker held its Integra LifeSciences (IART) position steady in Q4 2020 at 190 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #913.

Winslow Evans & Crocker first reported a position in IART in Q4 2013 and has held it in 29 quarters since. The position peaked at $14K in Q3 2018. 251 funds tracked by Wall St. Rank hold IART as of Q4 2020.

  • Winslow Evans & Crocker held 190 shares of Integra LifeSciences worth $12K as of Q4 2020.
  • Winslow Evans & Crocker left its Integra LifeSciences share count unchanged in Q4 2020.
  • Integra LifeSciences made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #913 holding.
  • Winslow Evans & Crocker first reported a position in Integra LifeSciences in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's Integra LifeSciences position peaked at $14K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.